Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 163Osteosarcoma 56Gastrointestinal Stromal Tumors 40Bone Neoplasms 32Glioblastoma 22Gliosarcoma 21Sarcoma, Ewing 20Dendritic Cell Sarcoma, Interdigitating 20Lymphoma 19Brain Neoplasms 18Neoplasms 17Central Nervous System Neoplasms 17Stomach Neoplasms 16Breast Neoplasms 16Ovarian Neoplasms 15Leiomyosarcoma 15Rhabdomyosarcoma 13Neuroblastoma 13Neoplasm Metastasis 13Recurrence 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Pancreatic Neoplasms 12Liposarcoma 12Astrocytoma 12Esophageal Neoplasms 11Chondrosarcoma 11Burkitt Lymphoma 11Sarcoma, Synovial 10Oligodendroglioma 9Neurofibrosarcoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Joint Diseases × Sarcoma × Clear all
NCT04842071 2024-02-07

18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment

Centre de recherche du Centre hospitalier universitaire de Sherbrooke

Phase 3 Unknown
2,500 enrolled
Sarcoma

Bone Diseases, Bone Neoplasms, Communicable Diseases, Joint Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡